(Q24236788)

PubMed

PubMed publication ID

20238334

30 October 2023

Rakesh Lodha

series ordinal

2

author given names

Rakesh

author last names

Lodha

1 reference

PubMed

PubMed publication ID

20238334

30 October 2023

Ravindra M Pandey

series ordinal

3

author given names

Ravindra M

author last names

Pandey

1 reference

PubMed

PubMed publication ID

20238334

Cochrane Database of Systematic Reviews

30 October 2023

publication date

17 March 2010

0 references

published in

0 references

cites work

Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Effectiveness of 3-day amoxycillin vs. 5-day co-trimoxazole in the treatment of non-severe pneumonia in children aged 2-59 months of age: a multi-centric open labeled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Comparison of two antibiotic regimens in the empirical treatment of severe childhood pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

An open, comparative evaluation of amoxycillin and amoxycillin plus clavulanic acid ('Augmentin') in the treatment of bacterial pneumonia in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Chloramphenicol alone versus chloramphenicol plus penicillin for severe pneumonia in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Trial of co-trimoxazole versus procaine penicillin G and benzathin penicillin + procaine penicillin G in the treatment of childhood pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Etiology and treatment of community-acquired pneumonia in ambulatory children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Comparison of miocamycin versus amoxycillin in lower respiratory tract infections in children. Clinical response and effect on natural killer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Role of atypical bacteria and azithromycin therapy for children with recurrent respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

A clinical and economic study of community-acquired pneumonia between single versus combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Comparative efficacy and safety of cephradine and cephalexin in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Successful shortening from seven to four days of parenteral beta-lactam treatment for common childhood infections: a prospective and randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Erythromycin versus amoxicillin for the treatment of pneumonia in children (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Narrow- versus broad-spectrum parenteral anatimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Etiology and response to antibiotic therapy of community-acquired pneumonia in French children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Chest radiography in children aged 2-59 months diagnosed with non-severe pneumonia as defined by World Health Organization: descriptive multicentre study in Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-3 (1999-2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Etiology of acute lower respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Diagnosis and management of pneumonia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Rapid detection of respiratory viruses by centrifugation enhanced cultures from children with acute lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Oral antibiotics versus parenteral antibiotics for severe pneumonia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Epidemiology and etiology of childhood pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

Antibiotics for community acquired pneumonia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

TRIAL OF CO-TRIMOXAZOLE VERSUS PROCAINE PENICILLIN WITH AMPICILLIN IN TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN YOUNG GAMBIAN CHILDREN

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

A therapeutic trial of cefotaxime versus penicillin-gentamicin for severe infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

7 January 2021

Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

7 January 2021

Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

7 January 2021

Benzathine penicillin for unilateral lobar or segmental infiltrates presumptively caused by Streptococcus pneumoniae in children 2-12 years old

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

7 January 2021

Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

7 January 2021

Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

7 January 2021

A randomized trial of chloramphenicol vs. trimethoprim-sulfamethoxazole for the treatment of malnourished children with community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

7 January 2021

[Etiology of pediatric inpatients with pneumonia]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

7 January 2021

Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

7 January 2021

Clinical trials on pediatric lower-respiratory-tract infection: results and comments with cefetamet pivoxil

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

7 January 2021

Comparison of Clarithromycin and Amoxicillin/Clavulanic Acid for Community-Acquired Pneumonia in an Era of Drug-Resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004874.PUB3

7 January 2021